SCHEMBL9104053

SCHEMBL9104053

O=C(O)N1CCN(c2ccc(OC(F)(F)F)cc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 1/20 0.62
CHRM4 P08173 3/20 0.52
MAPK1 P28482 3/20 0.51
L3MBTL1 Q9Y468 2/20 0.50
ALOX15 P16050 2/20 0.50
ALDH1A1 P00352 1/20 0.50
LMNA P02545 1/20 0.50
MAPT P10636 1/20 0.50
HTT P42858 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
FFAR4 Q5NUL3 1/20 0.48
EPHX2 P34913 1/20 0.47
CA12 O43570 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
ITGB3 P05106 1/20 0.46
ITGA2B P08514 1/20 0.46
RORC P51449 1/20 0.45
PPARD Q03181 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5238137 0.96 KCNA5 (0.58) KCNA5CHRM4MAPK1L3MBTL1ALOX15
SCHEMBL14437994 0.86 KCNA5 (0.61) KCNA5CHRM4MAPK1L3MBTL1ALOX15
SCHEMBL5536916 0.86 KCNA5 (0.61) KCNA5CHRM4MAPK1L3MBTL1ALOX15
SCHEMBL27999922 0.84 NOTUM (0.61) KCNA5CHRM4MAPK1LMNAHTT
SCHEMBL3922515 0.81 LMNA (0.61) KCNA5CHRM4MAPK1L3MBTL1ALOX15
SCHEMBL28816765 0.81 ENPP2 (0.45) KCNA5MAPK1FFAR4RORC
SCHEMBL25391320 0.81 CACNA1B (0.47) KCNA5CHRM4FFAR4PPARD
SCHEMBL25389457 0.81 CACNA1B (0.47) KCNA5CHRM4FFAR4PPARD
SCHEMBL25387175 0.81 CACNA1B (0.47) KCNA5CHRM4FFAR4PPARD
SCHEMBL26978098 0.81 CACNA1B (0.47) KCNA5CHRM4FFAR4PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3371164-B1 N-[2-(1-BENZYLPIPERIDIN-4-YL)ETHYL]-4-(PYRAZIN-2-YL)-PIPERAZINE-1-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS MUSCARINIC RECEPTOR 4 (M4) ANTAGONISTS FOR TREATING NEUROLOGICAL DISEASES NEUROCRINE BIOSCIENCES INC (US) 2022-03-16 EP disclosed
EP-2570418-A2 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-03-20 EP disclosed
EP-1555267-B1 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES OTSUKA PHARMA CO LTD (JP) 2013-01-16 EP disclosed
CN-1874777-B 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses HOFFMANN LA ROCHE 2012-07-04 CN disclosed
EP-2459571-A1 NITROIMIDAZOOXAZINES AND THEIR USES IN ANTI-TUBERCULAR THERAPY Global Alliance For Tb Drug Development (US) 2012-06-06 EP disclosed
CN-1874777-A 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses HOFFMANN LA ROCHE (CH) 2006-12-06 CN disclosed